P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

March 2006

Features

Pharmaceutical Approval Update

Dr. Goldenberg reviews letrozole (Femara) for early breast cancer, lenalidomide (Revlimid) for anemia, and abatacept (Orencia) for rheumatoid arthritis.
Marvin M. Goldenberg, PhD, RPh, MS

Alleviating Confusion and Preventing Fraud in the Medicare Part D Program

Doctors need help in assisting their patients to understand the new Part D rules. Patients need help to avoid being “scammed.” Dr. Stefanacci helps us sort it out.
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Prevalent Prescribing of Proton Pump Inhibitors:
Prudent or Pernicious?

The authors discuss the appropriate indications of PPIs and focus on the negative ramifications of the widespread and long-term use of these agents.
Co Q. D. Pham, BSC, BA, BScPharm, PharmD, Linda M. Sadowski-Hayes, PharmD, and Randolph E. Regal, BS, PharmD

Meeting Highlights

47th Annual Meeting and Exposition of the American Society of Hematology

Topics covered include therapies for multiple myeloma, leukemia, sickle cell disease, and lymphoma.
Reuben B. David

45th Interscience Conference on Antimicrobial Agents and Chemotherapy

The authors report on advances in the treatment of maxillary sinusitis, otitis media, skin and skin structure infections, diarrhea, gram-negative bacterial infections, zygomycosis, infectious mononucleosis, and combination therapy for HIV infection
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Book Review

“Ethics and the Pharmaceutical Industry”

The essays in “Ethics and the Pharmaceutical Industry” address the complex inter relationships between drug companies, clinicians, patients, and advocacy groups.
Alan Kaell, MD

Departments

Editorial

Hooray for BCMA

David Nash, MD, MBA discusses the virtues of bar-coded medication administration, a powerful technology developed to prevent medical errors.
David Nash, MD, MBA

Medication Errors

Survey on Perceptions of a Nonpunitive Culture Produces Surprising Results: Part 2

Matthew Grissinger, RPh, FASCP, presents Part 2 of a survey on frequent and fatal errors in the workplace and the effects of warnings and sanctions on the rate of errors.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Easing Information Overload: New FDA Rules Make Package Inserts More Reader-Friendly

Stephen Barlas discusses the differences of opinion about the FDA’s new rule regarding changes to drug package inserts, which are intended to clarify information for physicians and patients.
Stephen Barlas

Drug Forecast

Sildenafil Citrate (Revatio) for the Treatment of Pulmonary Arterial Hypertension

The authors review sildenafil citrate (Revatio) for the treatment of pulmonary arterial hypertension.
Amber Bell, PharmD Candidate, Myesha Davis, PharmD Candidate, Fran Close, PhD, Marlon Honeywell, PharmD, and Evans Branch III, PharmD